US › Healthcare

Accendra Health Inc (ACH)

US · Healthcare · Medical Distribution

$0.24-7.69%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$613.2M

Revenue YoY

-10.1%

Net profit

$-89.1M

EPS

$-0.19

EPS estimate

$-0.13

Net margin

-14.5%

EPS came in at -0.19 against a street estimate of -0.13 — a miss of 46.2%.

Key statistics

Market cap

$24.2M

Forward P/E

6.9

P/B

1.07

Book value

$-7.16

EPS (TTM)

$-1.44

52-week high

$5.60

52-week low

$0.27

50-day MA

$1.16

200-day MA

$2.40

Beta

1.57

Analyst view

Analysts rate Accendra Health Inc a hold (0 buy, 3 hold, 2 sell out of 5) with an average price target of $1.51.

Shareholding

Insiders

8.05%

Institutions

84.26%

Largest institutional holders

Fund	Stake
Coliseum Capital Management LLC	17.04%
BlackRock Inc	7.16%
Bank of America Corp	4.91%
Vanguard Capital Management, LLC	4.02%
D. E. Shaw & Co LP	4.01%
Charles Schwab Investment Management Inc	3.76%
Invenomic Capital Management, LP	3.66%
Marshall Wace Asset Management Ltd	3.36%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Accendra Health Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.